Breast Cancer Trial, Recruiting (NCT07040514)

Breast Cancer Trial, Recruiting NCT07040514 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07040514 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be at least 18 years old.
You must have already had your first appointment with a cancer specialist or surgeon for your diagnosis.
Your tissue sample slides and related reports from your diagnosis must be available for the research team to review.
You must be able to speak English.
You must be willing to take part in the research and will be given an information sheet explaining the study.
Pregnant women are able to join, as this research does not involve any physical risk to participants.

Who may not be able to join:

People under 18 years old are not eligible.
People diagnosed with DCIS (a specific early-stage breast condition — confirm with trial site if unsure whether this applies to you) are not eligible.
People who are unable to provide a written signature to give their consent are not eligible.
People from certain vulnerable groups are not eligible, including infants, minors, those who are unable to give informed consent, and those who are currently in prison or incarcerated.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07040514

Sponsor: Dartmouth-Hitchcock Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT07040514

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be at least 18 years old.
You must have already had your first appointment with a cancer specialist or surgeon for your diagnosis.
Your tissue sample slides and related reports from your diagnosis must be available for the research team to review.
You must be able to speak English.
You must be willing to take part in the research and will be given an information sheet explaining the study.
Pregnant women are able to join, as this research does not involve any physical risk to participants.

Who may not be able to join:

People under 18 years old are not eligible.
People diagnosed with DCIS (a specific early-stage breast condition — confirm with trial site if unsure whether this applies to you) are not eligible.
People who are unable to provide a written signature to give their consent are not eligible.
People from certain vulnerable groups are not eligible, including infants, minors, those who are unable to give informed consent, and those who are currently in prison or incarcerated.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dartmouth-Hitchcock Medical Center

Registry

ClinicalTrials.gov

Start date

10 July 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Participant self-rating of understanding of, and empowerment in relation to, their disease, as measured using pre and post-visit knowledge questionnaires, and survey after meeting with a pathologist.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov